Skip to main content
. 2022 Sep 6;12:978921. doi: 10.3389/fonc.2022.978921

Figure 6.

Figure 6

IEGPI score for immunotherapy response prediction. (A–E) IEGPI score’s potential as a tool for immunotherapy response prediction in melanoma, bladder cancer, and lung cancer; (F) the distribution of IEGPI score in different immunotherapy response groups with both PD-1 and CTLA4 treatment; (G, H) Kaplan-Meier curves of patients with different IEGPI score.